|
Dr. Day has spent twenty years in academic, industrial and pharmaceutical biotechnology research and development. He was most recently a research director in the R&D organization of Genencor International, Inc., (www.genencor.com) where he spent twelve years. While at Genencor, he led industrial biotechnology projects in a number of business areas, several of which led to commercial products. Dr. Day joined the Genencor Healthcare division at its inception where he designed, implemented, and ran their first healthcare program. Subsequently, he championed and directed a pre-clinical program targeted towards the treatment of acute cardiovascular indications. Dr. Day also played a number of other roles during his tenure at Genencor, including Head of Structural Biology and Head of Bioinformatics. Dr. Day is an inventor on more than 20 patents and patent applications and has authored numerous scientific articles. Dr. Day received his Ph.D. in biotechnology from Imperial College London. Subsequently he moved to the University of Cambridge where he carried out postdoctoral work on protein design in the research group of Professor Sir Alan Fersht, FRS. Dr. Day holds BSc and MSc degrees in chemistry from Portsmouth Polytechnic and the University of British Columbia, respectively. | 